News & Articles

Automated blood coagulation analyzers CN-3500 and CN-6500 using chemiluminescence enzyme immunoassay (CLEIA) technology launched to enhance the testing workflow

The novel lipid nanoparticles for mRNA delivery will enhance thermostability, biodegradability and safety, paving the way for new off-the-shelf therapies

VITROS Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies

Take lateral flow diagnostics to the next level with improved sensitivity for the future of IVDs

Gain insights into topics ranging from food and beverage testing to lab sustainability, Raman microscopy and seasonal viruses

The Collaboration is poised to deliver a range of ready-to-use bioprocess impurity reagent sets

Top talks and new resources detailing key developments in the fields of clinical research and diagnostics are now available on demand

Univercells Technologies will work with VectorBuilder to develop and optimize NevoLine Upstream platform and scale-X bioreactors for the production of custom viral vectors

The new media panel, gene kit and advanced resins help reduce manufacturing costs while increasing the viability of gene therapies

Watch exclusive interviews with leading industry experts on the importance of precision cold storage equipment

Watch this on-demand webinar to learn how an advanced spatial analysis workflow can be used to analyze the infiltration of CD8 positive cells across the tumor-stroma interface

The ultra-sensitive biomarker platform evaluates plasma neurofilament light’s utility across 13 neurodegenerative disorders, Down syndrome and depression

Catch up on this on-demand webinar to discover how combining multiplexing with HTS could streamline your drug discovery

The new XIENCE Skypoint stent received FDA approval in the U.S. and CE Mark approval in Europe

The self-collection kits facilitate raw saliva collection to aid global SARS-CoV-2 research and surveillance efforts

In this guest editorial, Michaël van der Jagt, CEO of Parx Materials, discusses how the human immune system can inspire innovation

The clinical data for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test demonstrated 100% sensitivity